ABSTRACT
Introduction
In clinical development of a new drug, a dose-response study is conducted to confirm existence of dose-response relationship. In general, efficacy rate of a drug increases with dose in a certain dose range of the drug and reaches to the maximum response. Some considers it to be important that the minimum effective dose andlor the maximum effective dose should be statistically identified. However, the minimum effective dose is usually defined as the lowest dose which shows statistically significant difference from the placebo. When a large placebo effect exists or when there are many non-responders, the difference of response rate between the lowest and highest doses may not be large enough to statistically identify the minimum effective dose in samples of moderate sizes.
In a dose response study of a drug on an efficacy variable, first of all it should be proved that there is statistically significant dose-dependent changes in the efficacy variable among several doses. When there are four or more dose levels, it is possible to estimate a dose-response curve by fitting a sigmoid curve and estimate the dose giving a specific amount of response which is clinically meaningful. Thus we are primarily interested in tests having high powers for broad ordered alternatives. Many authors have discussed tests against ordered alternatives in quantitative responses. Among them, Berenson (1982) and Shirley (1979 Shirley ( ),(1985 compared several tests with respect to powers and reported that, in general, Bartholomew's test and its nonparametric counterpart, which is proposed by Chacko (1963) and discussed by Shorack (1967) , are recommendable. Budde and Bauer (1989) discuss multiple test procedures for dose-finding studies. Kuriki, Hirotsu and Hayter (1989) and Hirotsu, Kuriki and Hayter (1992) propose a test to find change point, which is referred to as the max-t test. Ruberg (1989) discusses use of contrasts to identify the minimum effective dose in animal experiments. As far as the author knows, there are only a few authors, Armitage (1955) , Cochrane(1955) and Bartholomew (1959a) , who discussed testing ordered alternatives for binomial populations. This is why the Cochran-Armitage test is so widely used in clinical trials in parallel group comparisons of several doses of a drug.
In the present paper, we develop several tests for ordered alternatives for binomial populations and examine their type I error rates and power properties of several tests against ordered alternatives.
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The tests examined are analogues of tests for ordered alternatives for means of normal distributions with common known variances. The tests are derived from asymptotic normality of sample response rates, and the distribution of any test statistic examined is an unconditional approximate distribution derived from the asymptotic normal theory. The same test statistic is used to define conditional tests for the same alternative.
Conditional tests are useful when sample sizes are small. In section 2 , several types of ordered alternatives are discussed. In section 3, tests against the ordered alternatives described in section 2 are discussed. Some of the tests are obtained by modifying tests derived for quantitative responses. In later sections, we examine type I error rates and powers of the tests by computing exact unconditional distributions.
Before that in section 4 useful formulae for computing the distribution function of a test statistic are derived. Type I error rates and powers are examined in section 5 and 6 , respectively. In the final section 7 we illustrate sample size determination for a dose-response study.
2. Situation and hypotheses Let be K doses of a drug to be tested, where D, < < DK . The lowest dose D1 maybe a placebo. Suppose n subjects are randomly divided into K subgroups and the kth dose Dk is administered to nk subjects of the kth group. Let rk be the number of subjects who respond in the kth group, k =1, 1,••,K and let r = • •+rK . The results are summarized in a 2 X K contingency Kl p1 = ' = pk <P1+1 = ' = pK for some k (lsk<K-1), K2 : p, ==pk <pk+, s.PK for some k (lsk<K-1), where Ki is an analogue of a hypothesis discussed for normal means by Kuriki, Hirotsu and Hayter (1989) , and K2 is implicitly considered by Williams (1972) . Next, let us consider a model p1 = a + 136(Dk), k , K where a and j3 are unknown constants and &(x) is a monotonically increasing function of x>0. Then Ho implies that 13=0 and an alternative K3 is defined by Q >0. This hypothesis is implied by Cochran-Armitage test. Let us consider further a hypothesis K4 : pi <pk at least one k (1<ksK).
Note that K4 neither is implied by Ko nor implies Ko. Therefore this is not a dose-response hypothesis. Let us denote the observed response rate rklnk by Rk, k =1,-••, K , R=(R1,...,RK) and R=r/n. We call R the raw estimate of p. The sums r + + r. and n . +... + n • are denoted by r [v] and n[uv], respectively, for 1SusvSK.
An estimate of pk under Ko is given by well-known amalgamation procedure described by Bartholomew (1959a) and Barlow et al. (1972) . The formula is
We call R' = (R~ , ." , RK) max-min estimate of p = (p, , • • . , P K) under Ko. Large sample approximate test of significance levela of Ho against Ko is defined as "reject Ho whenx2 z v2 (a; K) , where x2 (a; K) is the upper a point of x2 statistic of Bartholomew (1959a) . The distributions function of this statistic is given by Bartholomew(1959a,b) and Barlow et al. (1972) . When K is 3 or 4, the approximate null distribution function can be exactly calculated.
Jonckheere type test
Jonckheere (1954) and Terpstra (1954) proposed a distribution free test of homogeneity against the ordered alternative Ko for continuous observations. We will slightly modify his statistic as follows; JM = Uri i where U is a centralized Mann-Whitney statistic. Then for quantai responses, we The test statistic is identical to the Cochran-Armitage test , which is discussed below, with equi-spaced score 8 (Dk)= 2k -1-K, k =1, ... , K.
3.3 Max Z test Kuriki, Hirotsu and Hayter (1989) proposed a test of a hypothesis of normal means µ, ,..• , µ, that for some k, µ, = µ k < µ k+, _• • • = µ K . Hirotsu, Kuriki and Hayter (1992) proposed applying the same idea to the rank order test. The test is referred to as the max t-test, because the test statistic is based on the maximum of K-1 t-statistics. The same test statistic is considered by Ruberg (1989) using step contrasts. Their idea is immediately applied to our situation for testing Ho against Kl by considering a situation where the common variance is known. The resultant test statistic is Zm,x = Max(Z, ,..•, Z,,), where Critical points of Zmax for the cases n 1 = = n K are obtained assuming asymptotic normality of R , =•• • = R K and are given by Kuriki, Hirotsu and Hayter (1989) . When the sample sizes are not equal, exact asymptotic distribution should be calculated based on the formula given by Kuriki, Hirotsu and Hayter (1989) and Hirotsu, Kuriki and Hayter (1992) . Ruberg (1989) gives conservative critical points. Let (a) be upper(x point of Zmax statistic calculated from Kuriki, Hirotsu and Hayter (1989) and Hirotsu, Kuriki and Hayter (1992) . Then the large sample approximate test is defined as "reject Ho when 3.4 Williams type test Williams (1971) proposed a stepwise test for determining the lowest dose level at which there is evidence for a difference from the control. A modification of his test for treating quantal response is the test of Ho against K2 and is defined by the statistic Z, where
Then the large sample approximate test is defined by "reject Ho when Z z Z(a) ", where Z(a) is the upper a point of Williams test statistic with infinite degrees of freedom, which is given in Williams (1971 Williams ( , 1972 .
A modified Williams type test
A modification of Williams test was suggested by Williams (1971) and was examined by Marcus (1976) . The test statistic can be modified for normal means with known variance. Thus we consider the following test statistic:
Then the large sample approximate test is defined by "reject Ho when ZM z ZM (a) ", where ZM (a) is the upper a point of modified Williams test statistic with infinite degrees of freedom, which is given in the table in Marcus (1976) for the case that all sample sizes are equal.
Cochran-Armitage test
Armitage (1955) and Cochran (1955) proposed a test of Ho against K3 for binomial populations. Let x = (x 1, , x K) be a given constant vector associated with dose levels like xk = 6 (Dk), k =1,•,K, • • where 6 (*) is a monotone increasing function and satisfy that x 1 x K and x 1 < x K . We refer to x as a score vector for the Cochran-Armitage test. Then the test statistic is given by Therefore Ho is rejected when Z is equal to or greater than Z( a). Cox (1958) shows that an equivalent test statistic is derived from a conditional argument for testing 13 =0 against j3 >0 when pk is given by a logistic model pk = 1/[I + exp(-a -13 6 (IA))], k =1,..., K. Taron and Gart (1980) show that the test is a C( a) test for the model pk = H(a+ j3 6 (Dk)), k =1, , K, where H is any monotone, and twice differentiable function. The test is defined as "reject Ho when ZD z ZD (a; K) ", where ZD (a; K) is the upper a point of Dunnett test with infinite degrees of freedom. The critical point is given at the line for infinite degrees of freedom given in the tables of Dunnett (1955) ,and Dunnett(1964) . When the heterogeneity of sample sizes is large, Bonferroni type test can be used: "If Z z( °`) then reject Ho", K-1 where Z L) is the upper a point of the standard normal distribution. Although the hypothesis K4 K-i K-i does not imply monotonicity of the dose-response curve, the Dunnett test is often used for testing dose response problems. Therefore, it is valuable to examine this test. Of course, it is possible to detect departure from the null hypothesis Ho by using the Dunnett test when there really exists an appreciable dose-response relationship, and in some situations the Dunnett test may be powerful. However, caution is necessary in interpretation of the test results.
Note on conditional test
So far we defined an approximate unconditional test for every test discussed above. When sample sizes are small it is possible to adopt an exact test which is conditional on the observed total number of responses. For any test statistic T(r) the probability is Therefore when is greater than a reject the null hypothesis. In what follows we discuss only the large sample approximate tests.
Properties of test statistics and their exact unconditional distributions
In this section, we study some properties of test statistics and their exact unconditional distributions. The observed numbers of responses rl,...,rx jointly have product binomial distribution n-a Thus for the given n and p we can exactly calculate the distribution of any statistic T( R) defined in section 3 by the formula where RT(t) is a set of r which satisfies T( r ) s t . We refer to the distribution F T (tl n, p) as exact unconditional distribution of a statistic T(R ) for given n and p. Now we introduce some terminology and notation. For given p, n and r, we write p R = (P K , ,P1) , o R = (nK, nl) and r R = (rK, • • • , rl) , respectively, and refer to them as reverse of p, n and r, respectively. Proofs of these propositions are trivial, so omitted. Note that the Williams type test statistic does not satisfy these properties. For example, suppose n=(10,10,10,10) and r=(3,1,7,9), then R=(0.3,0.1,0.7,0.9) and R*=(0.2,0.2,0.7,0.9), thus z =(0.9-0.1)1{0.52(1110+1/10)} for R. Whereas RG=(0.1,0.3,0.9,0.7) and R*o=(0.1,0.3,0.8,0.8) which give z =(0.8-0.1)/{0.52(1/10+1/10)}U2. Contrary to the Williams type test statistic, the modified Williams type test statistic gives the same ZM values.
Suppose that K* is one of the hypotheses Ko, Ki, K2, K3 and Kt, and p satisfies K*, then the conjugate of p also satisfies K*. Let (n, p) stand for an experiment where nk subjects are administered dose Dk with response probability pk, k =1,..., K . What we want to show is a sufficient condition that two experiments (n, p) and (m, q) give the same distribution of a given test statistic for testing Ho against K*. The main result is stated in the Theorem 1 and Theorem 2. 
(R) T(Rc). Then the exact unconditional distribution of T under the experiment (n, p) is identical to that under the experiment (nR, pC), that is,F T(tln,p) -FT(tIfR,p`)•
Proof Let r be any sample from (n, p). Then the sample rc from the experiment (nR, pc) has the same probability as r. Furthermore R and Rc are derived from r and rc, respectively and give the same statistic T
(R)--T(R'). Let RT(t) be the set of r giving T(R)t. Then
Thus the assertion is proved. Similar statement holds for a statistic defined by R*. Proposition 5: Let s = (s, , .
• , s K) be the conjugate of r. Then the max-min estimate of q under Ko based on s is given by R*c.
Proof: Denote Q k as the max-min estimate of qk based on rc. Then we have Thus the proposition is shown. Theorem 2: Let T=T(R*) be a statistic of R* satisfying T(R*) =T(R*c). Then the exact unconditional distribution function of T under the experiment (n, p) is identical to that under the experiment (n', pC), that is, FT (tjn,p) = F T(tI nR,pC) holds. Proof Let r be any sample from (n, p). Then rc is the sample from (n', pc) which gives the same probability element as that of r. Since R* and R*c give the same value of statistic T for the set of samples R*T(t)={r;T(R*)St}, next equality holds;
Thus the assertion of the theorem 2 was proved.
From the above theorems and proposition 1,2 and 3, it follows that each of the test statistics of the chi-square test, chi-bar square test, Jonckheere type test, Cochran-Armitage test with equi-spaced score, Max-Z test and modified Williams type test have the same distribution for (n, p) and (n', pC). Thus the chi-bar square test, for example, has the same power for the alternative p=(0.2, 0.3, 0.7) with samples n=(15,17,13) as for the alternative p=(0.3, 0.7, 0.8) with samples n=(13,17,15).
Example
Let us apply these tests to actual dose-response studies. Table 1 shows rates of patients who showed sufficient reduction of heart rates when administered 2.5mg, 5.0mg or 10mg of diltiazem under operation. Maximum likelihood estimates of Ri, R2 and R4 under Ko are 0.3200, 5703 and 0.5703, respectively, and R0.4722. We have Thus every test except for the Cochran-Armitage test indicates that the dose-response is significant at one percent level of significance of one-sided test. The Cochrane-Armitage test is significant at five percent level of significance. ZMax is given by Zi and ZD is given by Z2. Every test indicates that 5.0mg is more effective than 2.5mg. The chi-square test statistic for testing equality of response rates of 5.0mg and 10mg is 0.533. This indicates that the results that 10mg gave lower response rate than 5mg is highly possible by chance. Thus it can be concluded that 5mg is more effective than 2.5mg and is equivalent to 10mg, that is, 5mg is a plateau dose.
6. Type I error rates of the large sample approximate tests We derived large sample approximate tests of Ho against ordered alternatives. However, due to their discrete nature of response variables, and since they are asymptotically valid, the sample sizes may affect their validity. That is, when the sample sizes are small or moderate, the actual type I error rates possibly differ from the nominal significance level. It is worthwhile to examine agreement of the actual type I error rates and the nominal significance levels. For this purpose we calculate type I error rates by exact enumeration of the unconditional probability function F T(tJ n, p) at the nominal level 0.05, and 0.01. That is, the exact type I error rate is calculated by 1-F T(t(oc)In, p), where t( a) is the upper a point described in section 3. Since the number of dose levels in a dose-response study is mostly three or four, we show the results of K=3 and 4 in Table 2 and Table 3 Since the exact distribution of any statistic is discrete, it is usually impossible for any test to exactly attain the nominal level. So we accept the relative error less than five percent of the given nominal level. In Table 2 and 3, the super scripts + and ++ indicate that the actual level exceeds the nominal level by more than 5 percent and 10 percent of the nominal level, respectively. The symbolsand --indicate that the actual level is less than the nominal level more than 5 percent and 10 percent of the nominal level, respectively. The results of every test are summarized as follows.
(1) Chi-square test : The test is acceptable when no is equal to or greater than 20.
(2) Chi-bar square test : The type I error rate is more stable than the other tests studied. Even when no is equal to twenty, it keeps type I error rate at almost the nominal level. (3) Cochran-Armitage test : When K is four, it well keeps the nominal levels even when no is equal to twenty. However, when K is three, it is not so stable as chi-bar square test and is slightly conservative. This is because the test statistic for 3 samples case is actually a test of difference of proportions between the first and the third samples due to the equi-spaced scores. Thus except for the error variance there is no contribution of the second sample, which results in slow convergence to the asymptotic distribution. In case of four samples, all samples contribute to the test statistic, thus convergence is faster compared to the three sample case. (4) Max-Z test : The results show that the Max-Z test is not so stable as chi-bar square test but more stable than Cochran-Armitage test.
(5) Dunnett type test : The type I error rate seems fairly unstable even the size of each sample is fifty. One reason for the slow convergence to the asymptotic distribution may be that the test is essentially a two-sample test except for the estimates of variance. Therefore there are no contributions of other samples than the relevant pair of samples. This fact results in the greater discreteness of probability distribution.
(6) Williams type test : When no is equal to or greater than thirty the actual type I error rate is close to the nominal level. The second sample contributes to the test statistic to some extent, but the slow approximation to the asymptotic distribution is due to the isolate use of the first sample. (7) Modified Williams type test : The type I error rate of the modified Williams test is not so stable as that of the chi-bar square test. It is difficult to know why the type I error rate is so high for some cases even when sample sizes are 50. It is often said that for small samples, an exact test conditional on the given marginal totals should be used in order to avoid dependence of the type I error rate on the null response probabilities. However, since the actual type I error rate is between 95% and 105% of the nominal level for most response probabilities, the large sample approximate tests seem applicable for samples of which sizes are as large 
Power comparisons
In this section, we examine powers of the tests considered in section 3. Since the number of doses tested in clinical dose-response trials are usually three or four, we examined various non-decreasing dose-response patterns with dose levels of three or four. The power is given by P( T( R ) Z t( a)) for given p and n, which is obtained by exactly enumerating the product binomial probabilities as is in section 6. Among huge number of cases examined, only typical results are given in Fig.l, Fig2 and Table 4 . The significance level is five percent. In Table 4 , to identify powerful tests, the highest value among the six tests is underlined and values which do not differ from the highest values by more than one percent are highlighted by asterisks.
It is possible to identify which test is most powerful for some of the alternatives. For example for Ks, the Cochran-Armitage test should be most powerful. For Kl, the max-Z test should be most powerful. For K4 where p, < p Z =' = p K , the Dunnett type test seems to be very powerful, because all K-1 samples equally contribute to rejecting the null hypothesis. However, there are many situations where pattern of p is between these typical patterns. For such a pattern it is very difficult to predict which test is the most powerful. For quantitatively describing how the tests perform for a typical pattern of p, numerical comparisons by exact calculation of powers is inevitable.
First, let us summarize findings about cases of three dose-levels. Fig. i and Fig2 show power curves as functions of p2 when p2 changes from pi to ps. Figure 1 and Figure 2 show the case that p1=0. 20, p30.40, n=(60,60,60) and the case p1O.20, p3=0.50, n=(30,30,30) of the given test for several n's by the method described in the previous sections, and search for the appropriate n. When n = no(ni,...,nx), we can get the required sample size in the following manner. First, select several no, say nor, i=1,...,I, and compute powers P(no;), i1 ,...,I, thus we get pairs (no;,P(noi)), i=1,...,I. Next, fit a polynomial to the power plot (noi,P(na)), i=1,...,I and then get the solution to the equation that the polynomial value is equal to the required power. The first approximate no, say nA is obtained as the minimum integer which is not less than the solution to the above equation. The sample size vector nA(nl,...,nx) is an estimate of the sample sizes. Unfortunately the power function is not necessarily monotonic with respect to no, so it is better to calculate the powers for consecutive no around na to get a more precise value.
8.2 An example of sample size determination in a dose-response study When we calculate the required number of subjects for a dose-response study, we first estimate the response rate of each dose group and then select a testing procedure based on an expected response pattern and the primary hypothesis. The estimation of response rates is usually based on assumptions or earlier study results. Thus the assumed response rates for the planned study are not restricted to just one tuple of response rates. It is better to consider several plausible tuples of response rates . Furthermore, the power of the test depends on the response pattern. Therefore, it is advisable to calculate sample size for each test discussed in previous sections for several cases of response pattern , and choose the most efficient and also robust test. Let us consider an example, see Minaguchi et al.(1996) . Suppose we plan a dose-response study where four doses of a drug are compared based on a quantal response. The doses are equi-spaced on a logarithmic scale, so Di=D, D2=2D, D3=4D and D4=8D. The response rates of the lowest dose group and the maximum dose group were estimated to be pi=0.20 and p4 = 0.45 based on previous experiments. D3 is assumed to give almost the maximum effect, so that p3 is assumed to be 0.40 or 0.45. D2 is assumed to be less effective than D3. Based on these considerations, the power of each test was calculated for samples of size ni= n2= n4= n3= 25, 30, 35, 40 The chi-bar square test and Cochran-Armitage test were comparable for case 2, 3 and 5. The chi-bar square test was preferred to the Cochran-Armitage test for case 1 and 7, and vise-versa for case 4 and 6. From these results it was recommended to use the chi-bar square test and to enroll 40 subjects to each dose group. Because the chi-bar square test give the minimum value among seven tests of the maximum sample size among four combinations.
Sample sizes for several cases
It is very valuable to know the sample size for typical cases. From the results of power comparisons, it may be a good strategy to use the chi-bar square test or Williams test depending on response rates of intermediate dose levels. Table 5 gives sample sizes of required to assure 80% or 90% of powers for these two test of one-sided 5% level significance for experiments of three doses and p4 --pi = 0.20 and p4 -p i = 0.30. The sample sizes were calculated by the method described in section 7.3. Table 5a . Sample sizes of chi-bar square and W' ' ms type tests in case of three dose with 5% level of significance and 80% of power. 
